Design Therapeutics
DSGN
DSGN
74 hedge funds and large institutions have $542M invested in Design Therapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 7 closing their positions.
Holders
74
Holders Change
+11
Holders Change %
+17.46%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
26
Reduced
16
Closed
7
Calls
$2.68M
Puts
–
Net Calls
+$2.68M
Net Calls Change
+$2.68M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | – | -20,396 | Closed |
|
77
ProShare Advisors
Bethesda,
Maryland
| – | – | -10,755 | Closed |
|
|
PFS
78
Prospera Financial Services
Dallas,
Texas
| – | – | -1,404 | Closed |
|
79
UBS Group
Zurich,
Switzerland
| – | – | -998 | Closed |
|
|
CFGS
80
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
|
CS
81
Credit Suisse
Zurich,
Switzerland
| $0 | 31 | +31 | New |
|
82
Rockefeller Capital Management
New York
| $0 | 61 | +61 | New |
|